News | Proton Therapy | December 26, 2023

First four patients received proton therapy treatment on Dec. 19

 

The teams from KCPI and Mevion gather to celebrate the first patient treatment. (Photo: Business Wire)

The teams from KCPI and Mevion gather to celebrate the first patient treatment. (Photo: Business Wire)


December 26, 2023 — Kansas City Proton Institute (KCPI), the first physician-led proton therapy center in the Midwest, and Mevion Medical Systems announced today that the first four patients were treated at Kansas City Proton Institute on Dec. 19, with the MEVION S250i Proton Therapy System.

Kansas City Proton Institute recently opened the doors to its new facility that houses the region’s first Mevion compact proton therapy system. The newly built KCPI facility is 34,000 square-feet, with two floors, a partial basement and ample parking for patient ease. Its central location allows patients to receive the most advanced cancer treatment in a convenient and accessible way. Kansas City Proton Institute is located at 5300 Indian Creek Parkway in Overland Park, Kan. An open house and ribbon cutting for the facility will take place in early 2024.

“We know patients have choices when it comes to cancer care, and when they choose KCPI, we want them to know they have access to the best treatments, convenient care, and knowledgeable staff,” said Dr. James Coster, radiation oncologist for Kansas City Proton Institute. “KCPI is committed to providing the most advanced form of radiation therapy in an outpatient facility making proton therapy accessible and for all patients.”

KCPI features Mevion’s industry-leading HYPERSCAN® pencil beam scanning technology for Intensity Modulated Proton Therapy (IMPT) with a proton MLC. The powerful duo delivers faster and more precise, therapeutic doses of radiation to tumors while preserving surrounding healthy tissue and organs at risk, making proton therapy an ideal treatment choice for tumors near sensitive parts of the body such as the head and neck, spinal cord, breasts, esophagus, prostate, lung, bone, stomach, colon and bladder.

The MEVION S250i system at KCPI also integrates an advanced 3D imaging system and will install the C-RAD Catalyst PT surface-guided tracking system, enabling a cutting-edge Image-Guided Proton Therapy configuration for high-precision patient positioning and intra-fraction motion management.

“We congratulate Kansas City Proton Institute for starting treatment with the Mevion proton therapy system,” said Tina Yu, PhD, chief executive officer and president of Mevion Medical Systems. “Mevion is proud to be a part of KCPI’s dedication to offering this state-of-the-art cancer treatment in Kansas City and the surrounding area.”

Mevion is the system provider for 56% of the clinical single-room proton centers in the U.S. and its proton therapy systems have been used clinically for a decade to treat thousands of patients worldwide.

Proton therapy is a precise form of radiation therapy that can reduce the amount of unnecessary radiation exposure to healthy tissue, which has the potential to reduce side effects, facilitate target dose escalation, and lessen the risk of secondary malignancies. HYPERSCAN technology utilizes a unique combination of optimum spot sizes, hyper-fast layer switching and a novel multi-layer proton MLC. This powerful combination provides faster and more precise dose delivery and minimizes sensitivity to motion, allowing clinicians to deliver a full field of therapeutic radiation in a single breath-hold.

KCPI is affiliated with Kansas City Urology & Oncology (KCUC). Since 1999 KCUC has been the premier center for urology care in Kansas City. KCPI physicians have extensive experience treating an array of cancer types, including cancers of the prostate, head/neck, breast, lung, brain, gastrointestinal system, liver and skin.

For more information: www.KCUC.com


Related Content

News | Radiation Therapy

June 19, 2024 — RaySearch Laboratories AB announced a milestone in radiotherapy technology where RaySearch’s RayStation ...

Time June 19, 2024
arrow
News | Artificial Intelligence

June 17, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care ...

Time June 17, 2024
arrow
News | Proton Therapy

June 14, 2024 — Atlantic Health System, an integrated health care system setting standards for quality health care in ...

Time June 14, 2024
arrow
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 14, 2024
arrow
News | FDA

June 10, 2024 — Siemens Healthineers announces the Food and Drug Administration clearance of the Biograph Trinion, a ...

Time June 10, 2024
arrow
News | Breast Imaging

June 7, 2024 — Scholars and studies funded by Susan G. Komen(R), the world’s leading breast cancer organization ...

Time June 07, 2024
arrow
News | Radiopharmaceuticals and Tracers

June 7, 2024 — Shine Technologies, LLC, a pioneer in next-generation fusion-based technology, today announced a new ...

Time June 07, 2024
arrow
News | Information Technology

June 4, 2024 — International medical imaging IT and cybersecurity company Sectra has launched a new diagnostic IT module ...

Time June 04, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

As we flip the page to a new month on our calendars, here is a look at the Top 10 pieces of content viewers were reading ...

Time June 04, 2024
arrow
News | Radiation Oncology

June 3, 2024 — The American Society for Radiation Oncology (ASTRO) published an updated clinical guideline that details ...

Time June 03, 2024
arrow
Subscribe Now